key: cord-0861176-cehn1ztz
authors: Kiessling, Karalyn A; Iott, Bradley E; Pater, Jessica A; Toscos, Tammy R; Wagner, Shauna R; Gottlieb, Laura M; Veinot, Tiffany C
title: Health informatics interventions to minimize out-of-pocket medication costs for patients: what providers want
date: 2022-02-24
journal: JAMIA Open
DOI: 10.1093/jamiaopen/ooac007
sha: d53657db756a7a9ff3cf9218d0b74bce6b79c56a
doc_id: 861176
cord_uid: cehn1ztz

OBJECTIVE: To explore diverse provider perspectives on: strategies for addressing patient medication cost barriers; patient medication cost information gaps; current medication cost-related informatics tools; and design features for future tool development. MATERIALS AND METHODS: We conducted 38 semistructured interviews with providers (physicians, nurses, pharmacists, social workers, and administrators) in a Midwestern health system in the United States. We used 3 rounds of qualitative coding to identify themes. RESULTS: Providers lacked access to information about: patients’ ability to pay for medications; true costs of full medication regimens; and cost impacts of patient insurance changes. Some providers said that while existing cost-related tools were helpful, they contained unclear insurance information and several questioned the information’s quality. Cost-related information was not available to everyone who needed it and was not always available when needed. Fragmentation of information across sources made cost-alleviation information difficult to access. Providers desired future tools to compare medication costs more directly; provide quick references on costs to facilitate clinical conversations; streamline medication resource referrals; and provide centrally accessible visual summaries of patient affordability challenges. DISCUSSION: These findings can inform the next generation of informatics tools for minimizing patients’ out-of-pocket costs. Future tools should support the work of a wider range of providers and situations and use cases than current tools do. Such tools would have the potential to improve prescribing decisions and better link patients to resources. CONCLUSION: Results identified opportunities to fill multidisciplinary providers’ information gaps and ways in which new tools could better support medication affordability for patients.

Medication costs in the United States are among the world's highest. 1 Of medications purchased in the United States, 70% include patient out-of-pocket costs 2 and 24% of adults taking prescription drugs have difficulty affording them. 3 Higher out-of-pocket costs are associated with greater odds of prescription abandonment 4 and cost concerns contribute to lower adherence of people with chronic conditions. 5, 6 It is estimated that 20-30% of diabetes-and hypertension-related prescriptions are never filled. 7, 8 Not taking medications as prescribed can worsen chronic conditions 3, 9 and increase emergency room visits and hospitalizations. 10, 11 Low-income patients are disproportionately affected by costs, especially when uninsured or underinsured. [12] [13] [14] African American and Hispanic populations have consistently worse chronic disease outcomes than Whites 15 and are most affected by cost-related adherence barriers. [16] [17] [18] Many prescribers report considering patients' out-of-pocket costs in making treatment decisions. One US study showed that 78% of physicians routinely consider costs when prescribing generic drugs; a more common practice for those with larger proportions of Medicaid-insured patients. 19 A survey of nurse practitioners (NPs) found that they considered costs in 58% of prescriptions. 20 Prescribers also consider attention to patient medication costs important. A physician survey found that most believed it was important to minimize out-of-pocket cost (94%) and total cost (94%) when equally safe and effective medications were available. 21 Similarly, 90.3% of NPs in a US survey thought cost should be considered when prescribing. 20 To address costs, physicians and NPs report using strategies such as switching to generic medications, 22 ,23 although they are not always more affordable. 24, 25 Physicians may also reduce costs by discontinuing nonessential medicines, 22 especially for older adults. 26, 27 Additionally, providers often adopt patient-by-patient approaches to affordability challenges via resources like discounts, drug coupons, and assistance programs. 28, 29 Despite such documented efforts, several known barriers limit provider access to information needed to address patient medication affordability issues. Physicians face information gaps concerning list prices and copayments 21 ; this may make it difficult for physicians to respond to copayment changes unless these are large and widely adopted across insurers. 30 Physicians and NPs may also have difficulty estimating list prices. 28 Furthermore, while patients can provide information concerning their needs, 31 and may influence prescribing decisions, 32 not all disclose cost barriers. 2, 33 Expanded social and economic risk screening 34 may make financial information more available at the point of care. Published screening instruments often ask about financial strain, including payment difficulties. [35] [36] [37] However, it is unclear whether providers consistently have access to such information when developing treatment plans or addressing affordability barriers. Furthermore, the number and complexity of cost alleviation resources may limit both patients' and providers' abilities to navigate them efficiently. For example, some pharmaceutical companies offer charitable assistance programs that provide free or lowcost medications to eligible patients, 38 usually based on income and insurance access. Other charitable programs may have related restrictions, such helping only insured individuals. 39 Multiple strategies have been proposed to address some of these barriers, and more systematically address patients' medication costrelated challenges. 40 Notably, price transparency to influence clinical decisions is receiving increasing attention, including policy efforts to prevent "surprise billing," 41 for out-of-network providers. 42, 43 For prescribing decisions, the Centers for Medicare and Medicaid Services (CMS) issued a rule requiring Medicare Part D health plans to adopt real-time benefit tools (RTBT) that integrate with e-prescribing or electronic health record (EHR) systems by January 1, 2021. Such RTBTs should provide "complete, accurate, timely and clinically appropriate patient-specific real-time formulary and benefit. . .information (including cost, formulary alternatives, and utilization management requirements)." 44 Multiple e-prescribing and EHR systems have launched RTBTs with price transparency features. [45] [46] [47] Some scholars advocate for EHRs to display drug prices, 48 and surveys show that healthcare providers want information about out-of-pocket medication costs and lower-cost alternatives. 49 Some RTBTs add cost information to after-visit summaries (AVSs), which may help surface patients' costs concerns. However, researchers criticize the CMS rule due to the lack of RTBT interoperability standards, 50 and evidence that EHR-based price transparency influences medication costs has been inconsistent. [51] [52] [53] [54] [55] [56] [57] [58] [59] Furthermore, although new tools such as RTBTs may address prescribers' desires for point-of-care tools to recommend alternatives, 60 there has been little attention to the needs and perspectives of a range of providers engaged with addressing patients' medication affordability challenges, such as pharmacists, nurses, social workers, and advanced practice providers, in designing such tools. Pharmacists assist patients in identifying cost-effective insurance plans 61, 62 and selecting lowercost medications. 63, 64 Nurses assess healthcare resource access, 65, 66 including medications. 67 Social workers connect patients to costalleviation resources. 68 ,69 Yet, we know little about the cost-related information gaps diverse providers face, how current informatics tools support their work, and their design preferences for future tools.

We investigated diverse providers' perspectives on medication cost information gaps and how they address patients' cost barriers. Further, we investigated perceived strengths and weaknesses of current cost-related information tools and potential informatics features that might improve cost-reduction efforts.

We recruited healthcare providers from a US not-for-profit community-based hospital system that includes 850 physicians and advanced practice providers, 100 clinics, and 9 hospitals, serving over 1 million patients across 15 counties in 2 Midwestern states. The system provides a variety of informatics tools to help clinical teams identify and address medication cost-related issues. These include EHR-based social needs screening/documentation tools in 8 of 14 clinical settings represented in the sample. Affordability resources include sources listed on a Sharepoint site and cost-related applications such as GoodRx on providers' devices. An EHR-based real-time eligibility (RTE) system handles prescription pre-authorizations. In February 2020, the system launched an EHR-integrated RTBT; interviews were conducted between March and September 2020. Only ambulatory prescribers could use the RTBT directly (see Table 1 for details regarding participant RTBT access). The RTBT contained insurance information from all major payers, including data for 88-95% of patients. Uncovered patients included uninsured patients or those whose insurers had not contracted with the RTBT vendor. When ordering medications for insured patients, clickable alerts indicated availability of lower-cost medications. When clicked, these presented alternatives based on copayment tier as a tier number or copayment amount. Medications with lower tiers could be substituted. Prior authorization information was updated simultaneously. The system could only consider 1 medication and 1 payer at a time and required staff pharmacy benefits verification during patient rooming. It also added information on medications and out-ofpocket costs to AVSs provided to patients on paper afterwards. At system launch, RTBT use instructions were distributed via email to all clinical providers.

We purposively sampled providers in clinical areas pioneering efforts to screen for and address patient social determinants of health (SDOH; n ¼ 19 participants from 7 clinical areas)-of which financial strain and inability to afford medications is an example. We also sampled providers from clinical areas that had not implemented SDOH screening (n ¼ 19 participants from 7 clinical areas). We captured a diverse sample of clinical settings and professional roles, including 5 participants with independent prescribing privileges, and 3 pharmacists who could prescribe or change prescriptions under a collaborative practice agreement. We also included providers who deal with medication affordability challenges in other ways (eg, nurses, social workers). A researcher (SRW) within the health system led email recruitment. Of 67 providers invited, 38 agreed to interviews (57%). Most who did not participate did not respond (23/29, 79%); 4 declined (14%); 2 were unable (7%).

We conducted semistructured telephone interviews from March to September 2020. Many participants retained clinical duties despite the coronavirus disease 2019 (COVID- 19) pandemic. SRW collected demographic information via a preinterview survey. SRW called interviewees, completed the consent process, administered the survey, and connected BEI and KAK for interviews. BEI (male, PhD candidate) conducted 45-60 minute interviews with KAK's assistance (female, PhD candidate). The research team collaboratively developed and pilot-tested the interview guide to ensure feasibility and clarity. Participants were aware of the research goal. Additionally, the team reviewed 7 social needs screening tools from interviewees' units.

In the initial 36 interviews, 2 participants were using the RTBT, 2 were not direct users but supported others using it, and 1 had been involved in RTBT implementation but did not use it directly. To gain more focused information on the RTBT, the team used a supplemental interview guide to reinterview 1 provider involved in implementation and interview 2 new physicians about their RTBT experiences (see Table 1 for final details). Data saturation was reached when later interviewees' responses confirmed themes without contributing new content. 70 Interviews were audio-recorded and professionally transcribed. BEI verified transcripts and them to NVivo for analysis. The team conducted open, in vivo, and structural coding in the first round, followed by second-and third-round focused coding to develop themes. 71 KAK was the main coder in the first and second rounds; BEI coded 20% to check inter-rater reliability. The kappa coefficient was 0.65, indicating "strong" agreement. 72 TCV was the main third-round coder, providing investigator triangulation and ensuring credibility. 73 TCV focused on refining themes and confirming evidence. For additional triangulation, other team members helped develop themes and evaluate evidence. 73 Codebooks were created for each round.

The average interviewee age was 43 (range 32-61); 84% were female (16% male), and 84% were non-Hispanic White (Table 1) . Interviewees included nurses, social workers, pharmacists, administrators, and physicians, with an average of 15 years of clinical experience (range 1-38) and 10 years' experience at the health system. Seven participants (18%) had direct or indirect experience using the RTBT.

When aware of barriers, most participants reported working toward reducing patients' costs. Three mentioned reducing the amount of medication that a patient takes (Table 2 ; main themes in the tables are bolded in the text) by deprescribing, or by improving patient health behaviors to reduce need. Another action was prescribing comparable medication at lower cost, reported by 14 participants, including physicians, pharmacists, nurses, and the NP. Prescribers learned about cost barriers directly from patients, or indirectly from other staff. They chose alternatives based on prior knowledge, recommendations from other providers such as pharmacists, or existing tools. Two physicians who used the RTBT indicated that it assisted; 1 stressed its value for surfacing insurance-related cost issues. Similarly, a pharmacist used the Medicare portal to identify lower-cost medications for Medicare-insured patients.

Sixteen providers attempted to provide resources to help patients stay on current regimens, including 7 prescribers (3 physicians, 3 pharmacists, and 1 NP). Prescribers have access to an in-system Medication Assistance Program (MAP) that provides prescription medications to patients who meet personal income criteria, and which is supported by the hospital foundation. The MAP was a key resource for 28 providers, but because some patients were ineligible, all mentioned other options. Community assistance through external organizations was available for select medications. Providers also used medication samples as shorter-term solutions.

Four participants-including 3 nurses-mentioned resources to address other adherence barriers, such as food assistance. Participants viewed transportation access as a significant barrier and con-nected patients to transportation services or mail-order pharmacies. Two described physically delivering medication to patients' homes.

Fifteen informants-representing all included clinical rolesreported information gaps regarding patients' financial resources and ability to pay. Eight related learning about problems after patients refused to fill prescriptions, had endured financial burdens, or were not taking their medication. Useful information such as past-due healthcare bills or social needs screening information was not always available to certain people or units outside of where the screening took place. Some information was in narrative notes or otherwise difficult to locate within the EHR. Providers often relied upon patients for financial information. In areas without formal social needs screening, 4 reported regularly asking patients about cost; 7 stated that patients brought it up themselves ( Table 2) .

Seventeen providers, including 7 prescribers, reported lacking reliable, comprehensive, and/or timely information about the true cost to patient, and for whole regimen (see Table 2 ). Although the RTBT provided this when ordering and through the AVS, 2 prescribers did not yet have access to it due to phased implementation and 1 with access had not used it. Two who used it wanted greater coverage of insurers and patients; 2 others were uncertain of the information's quality (see below). Static resources such as Medicare reference guides were not tailored to patients' situations (although more recently released Medicare Part D tool provides tailored information). Pharmacies offered reliable information, but using them required phoning or placing advance orders. Finally, providers lacked information about the costs of patients' full regimens.

Five providers highlighted information gaps regarding the impact of changes in patient insurance status on cost, including whether patients had reached their deductibles or were in the Medicare "donut hole," (a known coverage gap). 74 Annual changes in formularies and deductibles also affected coverage and costs. Although the RTBT indicated copayments for patients in the donut hole when ordering, such information was not easily accessed if pricing changed afterwards due to patient insurance status changes.

Five providers found some cost-related information unclear. Copayment tiers displayed via the RTBT and external websites caused the most confusion; actual dollar values were not standardized across insurers (Table 3 ; main themes bolded, subthemes italicized in the text). Display decisions were controlled by insurance companies, not the health system.

Seven providers were uncertain about the quality of cost-related information to which they had access. Uncertainty was expressed about external information sources, the RTE system, and the RTBT. Three RTBT users expressed uncertainty about quality related to insurance information currency, with 2 providers questioning why the pricing information button appeared when it did. They questioned whether the system worked. However, 3 expressed confidence in the quality of information displayed in the RTBT and AVS.

According to 8 participants, cost-related information is not getting to all of the people who may need it; this primarily concerned the "true cost to the patient." According to 4 prescribers, the separation of decision-making and order entry meant that decision-makers did not see the RTBT. This occurred in office visits and occasionally after patients visited the pharmacy. Ten participants noted that nonprescribers need cost information for work with patients when an- swering patient questions, resolving affordability challenges, or caring for the patient at other units. Six providers said cost-related information was not always available when needed. True cost information is needed at different points in the medication ordering process. One physician wanted to be able to look up costs before ordering. Two wanted access when reviewing already-prescribed medications to address affordability challenges. One nurse identified challenges with the AVS print-outs provided to patients after their visit was over. Nevertheless, 5 providers-including 3 prescribers-said information provided when ordering is available when needed, at least sometimes. However, they all wanted information to be available at other points, too.

Finally, 8 providers in diverse roles found some information difficult to access. Four mentioned fragmented information about ability to pay, often located in narrative notes-indeed, 9 at sites without SDOH screening said they documented affordability challenges in notes. Four said information about resources for patients was fragmented, except for the MAP. A related issue for 4 providers was nonintegration of resources into existing systems, particularly concerning external applications and websites on costs and costalleviation resources. In contrast, providers appreciated RTE and RTBT integration into the EHR.

Thirteen participants-including 9 prescribers-wanted expanded support for choosing medications (see Table 4 ). Four wanted wider coverage of patients and insurers so they could use the RTBT's patient-specific cost information in more clinical circumstances, including settings where Medicare Part B prescriptions were common. Two wanted a system to present a listing of available options in a drug class rather than in the current one-by-one display. Five wanted a display that allowed providers to compare costs and see exact price differences. One wanted cost comparisons integrated with clinical information about medications. One NP suggested that a system include varied payment options, including those covered by insurance and those from pharmacies like those advertised in GoodRx.

There was also interest in user control over interaction. Five providers wanted user-initiated interactions with cost information, such as inquiry buttons. Additionally, there was a desire for flagging options to which users could respond. Providers imagined patients using the tool in conversation with patients.

Eight providers-including 5 nurses-wanted quick-reference sources to facilitate discussions about costs. Primarily, this was envisioned as allowing searches for patient-specific cost information within current workflows, but often for nonprescribers or outside of medication-ordering workflows. These could be used to answer patient questions at discharge planning and would eliminate steps such as asking colleagues, calling pharmacies, or making referrals to insurance pre-authorization departments. Two providers wanted links and lookups to use for more general cost information when preparing for discussions with patients or answering colleagues' queries. Six recommended personalized patient-facing reports of medication costs and coverage that would inform them about costs before prescriptions were filled; provide records of expenses to date; and provide updates on formulary coverage. Four providers found providing cost information to patients via the AVS helpful; one recommended incorporating this information into the patient portal; another recommended providing a spreadsheet.

Six providers, including 4 social workers, wanted tools for streamlining medication resource referrals. Four felt this could involve centralization and standardization of affordability resource information. Two social workers wanted an assessment of medication needs and available resources to make it easier to understand size and duration of problems and possible actions. Four providers wanted similar patient-facing cost-alleviation resource information for their independent use.

Six providers advocated a tool to identify patient status related to costs, including 3 nurses, 2 administrators, and 1 pharmacist. They thought a centrally accessible visual summary of patient outof-pocket costs could keep affordability issues in view through a snapshot, summary, or demographic page.

Study findings identified themes regarding how providers seek to address medication cost barriers, how current informatics tools do or do not serve those activities, and desired features of future tools. Participants reported 3 strategies for reducing patient medication costs: reducing the number of prescriptions taken, prescribing less expensive but comparable medications, and connecting patients to cost-alleviation resources. Providers in settings without SDOH screening lacked information about ability to pay; even with screening, this information could be difficult to locate within the EHR. Sometimes, providers discovered financial barriers only after clinical encounters. Notably, fixing such problems is not typically reimbursed. Providers also reported difficulty with gauging medication regimens' true costs. Prescription information available through the RTBT was not always available when needed. Cost clarity was lacking when insurance situations changed, and due to tier-based copayment information. Quality questions emerged regarding external resources and uncertainty about how existing tools such as the RTBT functioned; this might be improved by offering provider training in future implementations. Nevertheless, cost-related infor-mation was not available to everyone who needed it due to workflow/system mismatches and permissions based on prescribing privileges. Although the RTBT integration into the ordering process was valued, cost-related information was also desired during other workflow phases. Fragmentation and lack of EHR integration impeded access to need and referral information. Providers described desired use cases for future tools. Study results aligned with prior findings concerning prescribing providers' strategies for addressing affordability, such as prescribing comparably effective, less costly medications. 22, 23 Our findings extend prior research by documenting involvement of providers from multiple disciplines in each strategy. Moreover, results point to gaps in support for technology support for members of these other disciplines. For example, because prescribers may not enter their own orders, the RTBT may not always be used by relevant decision- . ." (P23, Nurse) "Just a simple tab would be wonderful!. . . so we will know where to go to get that information if it is in regards to client medications. . .we could go to for patient discounted rates or something like that. . ." (P14, Nurse) Nonintegration of resources into existing systems: ". . .there are resources out there. . .but the fact that they're not. . .integrated into our system makes it' harder to use them. . .Fingertip Formulary. . .you have to go to a different system. . .it's going to take a lot of time and it's not going to become something that I can use while the patient's sitting there." (P34, Pharmacist) "[Medication cost apps are]. . . so user-dependent. . .that's going to be at the forefront for some providers and. . .not for others." (P7, Physician) makers. These findings suggest the importance of ensuring that cost tools support all providers involved in reducing costs. This is especially important given how large physicians' patient panels can be, and the limited time which they may have available to address cost issues with individual patients. In facilitating the work of a wider range of providers, future tools should also support a wider range of use cases. Such use cases involve prescribing decisions made when providers are not placing orders, facilitating changes made by ancillary staff, and links to relevant cost-reduction resources. Our findings are also consistent with prior work suggesting true out-of-pocket medication cost information is not easily accessible. 21 In our study, information gaps persisted even in the RTBT context. This may partly be because only 4 participants had used the RTBT directly, whereas 3 had used the RTBT indirectly or been involved in its implementation. Yet, RTBT users' experiences revealed gaps related to missing insurers and insurance coverage information. Missing insurance data is a long-standing problem with real-time pharmacy benefits information. 75 This suggests ongoing needs to incorporate up-to-date, comprehensive coverage information into RTBTs; one solution is continued expansion of contracts between insurers and RTBT vendors. Furthermore, reliance on confirming insurance at the beginning of a visit may have led to more missing data. Thus, similar to other interventions in which patients helped improve the accuracy of their medication documentation, 76 new tools might address data quality concerns by enabling coverage confirmation during a portal-based check-in.

Others also have found that providers may question the quality of insurance information in RTBT-type systems. 77 In our study, RTBT quality concerns were partly linked to a lack of understanding of the RTBT's logic, including reasons for clinical alerts and the source of information behind the information included in RTBT features like the AVS. Design approaches such as providing references and rationales for alerts or recommendations 78, 79 and collecting local validation data on RTBTs' cost information may increase trust. 77 A further quality issue emerged due to the dynamic nature of insurance information, which could undermine data currency. Accordingly, providers wanted tools to account for total expenditures over the course of a year or after insurance changes regarding medication coverage. Tools to support workflows to correct this, such as a reviewing annual benefit updates and revisiting prescriptions as necessary might also help systematically address these concerns.

Findings also pointed to providers' knowledge gaps regarding patient's ability to pay and difficulties in relying on patients to disclose challenges. Prior research has shown that patients may not disclose barriers due to embarrassment or doubt that providers can help. 80, 81 Patients may not discuss cost unless asked, 82 such as when providers note adherence problems. 23, 60 Similarly, we found that information about challenges might be elicited only after prescriptions went unfilled. However, some providers reported surfacing cost barriers by routinely asking about cost concerns, particularly those working in the 8 clinical settings that had implemented SDOH screening programs. In related work, we have also shown that some patients are willing to disclose more detailed information about their abilities to pay for medications if this can lead to them being prescribed more affordable medications. 83 However, as described elsewhere, 31 access to patientreported SDOH data can be limited by security permissions and omission from structured EHR fields. To improve access to information about patients' abilities to pay, this study recommends using clear visual summaries in easily accessible EHR locations. Making AVS cost summaries available during visits, rather than just after, could facilitate cost-related conversations between providers and patients. [84] [85] [86] [87] [88] [89] Patientfacing reports and materials advocated by participants may assist here, although health literacy concerns suggest that special care should be taken to ensure that their design follows relevant communication guidelines, such as use of plain language or pictographs. Recent work 88, 90, 91 highlights opportunities to expand cost-related content in patient decision aids; our findings suggest the need for exact dollar values rather than tier numbers. As in previous work, 60 we found that physicians, NPs, and pharmacists refer patients to discount services such as GoodRx and $4 generics and physicians refer them to assistance programs. 22 Findings newly highlight how some providers tackle medication barriers by addressing other needs, such as transportation. This reveals the value of integrating information about medication referrals and resources into general community resource referral platforms that have databases of social service agencies, suggest referrals based on screening, send referrals, track outcomes, and integrate with EHR systems. 92 While such platforms may include some medication access resources, there is likely a need to expand to include cost resources currently used by our participants, such as GoodRx. However, as discussed elsewhere, 93 human assistance in choosing and facilitating connections to referral sources will still be needed.

Our study included several limitations. It was conducted in 1 region in the Midwest, at 1 health system with 1 EHR system. While this may limit the generalizability of the results, a strength is that we interviewed providers in 8 different professional roles to gather a variety of viewpoints. A unique characteristic of the health system was the MAP, which other systems may not have. This study's providers may have thus been more aware of medication assistance needs due to this resource. This may also be a strength, as informants were already aware of at least 1 relevant resource. The health system's RTBT was intended for prescribers only; only 4 prescribing providers had used it directly, and 1 implementer and 2 secondary users discussed its use. The study took place during the COVID-19 pandemic; although many participants retained clinical duties, they may have had limited bandwidth to learn about new tools. Therefore, our findings should be confirmed in future studies. It is important to emphasize, however, that the novel features that informants prioritized are not currently available in the health system's RTBT.

Providers lacked information to support medication affordability for patients; they wanted data on actual patient costs for all pre-scribed medications, patients' ability to pay, and less fragmented affordability resources. There is a clear role for informatics tools to provide such information to facilitate medication affordability. Our findings should contribute to developing stronger tools, ideally using processes that engage diverse, multidisciplinary providers in their design, implementation, and use.

This work was supported by Parkview Health (no grant number).

TCV, BEI, TRT, JAP, and LMG designed the study. SRW recruited participants. BEI and KAK conducted interviews. BEI, KAK, and TCV coded and analyzed data. KAK and TCV drafted the article. All authors provided critical feedback on the article, and approved the final version.

Paying for prescription drugs around the world: why is the U.S. an outlier? The Commonwealth Fund

Strategies used by adults aged 18-64 to reduce their prescription drug costs

KFF Health tracking poll -February 2019: prescription drugs -methodology. KFF

The epidemiology of prescriptions abandoned at the pharmacy

Barriers to medication adherence in poorly controlled diabetes mellitus

Impact of out-of-pocket pharmacy costs on branded medication adherence among patients with type 2 diabetes

Meta-analysis of trials of interventions to improve medication adherence

Interventions for enhancing medication adherence

Cost-related medication underuse: strategies to improve medication adherence at care transitions

Out-of-pocket medication costs, medication utilization, and use of healthcare services among children with asthma

Prescription drug cost sharing: associations with medication and medical utilization and spending and health

Understanding the patient experience of cost-related non-adherence to prescription medications through typology development and application

Non-adherence to cardiovascular medications

The effect of health insurance on prescription drug use among low-income adults: evidence from recent Medicaid expansions

The social determinants of chronic disease

Trying to make things right: adherence work in high-poverty, African American neighborhoods

Barriers to adherence and hypertension control in a racially diverse representative sample of elderly primary care patients

Medicare beneficiaries and free prescription drug samples: a national survey

Physician consideration of patients' out-of-pocket costs in making common clinical decisions

Out-of-pocket prescription costs and nurse practitioner prescribing: A national survey

Physicians' opinions about responsibility for patient out-of-pocket costs and formulary prescribing in two Midwestern states

Physician strategies to reduce patients' out-of-pocket prescription costs

Psychosocial information use for clinical decisions in diabetes care

Medicare spending on brandname combination medications vs their generic constituents

Trends in use and expenditures of brand-name Atorvastatin after introduction of generic Atorvastatin

Principle of rational prescribing and deprescribing in older adults with multiple chronic conditions

Reconsidering medication appropriateness for patients late in life

Assessment of prescribers' knowledge of the cost of medications

SingleCare Administrators. SingleCare Homepage. SingleCare. 2021

Do physicians respond to the costs and cost-sensitivity of their patients?

Physicians' perceptions of the impact of the EHR on the collection and retrieval of psychosocial information in outpatient diabetes care

Comprehensive process model of clinical information interaction in primary care: results of a "best-fit" framework synthesis

Perception of generic prescription drugs and utilization of generic drug discount programs

The prevalence of social care in US health care settings depends on how and whom you ask

AccessHealth Spartanburg: social determinants screening tool

The Health Leads Screening Toolkit. Health Leads

Using pharmaceutical company patient assistance programs: a volunteers in healthcareguide

Financial eligibility criteria and medication coverage for independent charity patient assistance programs

Trump signs executive orders on drug prices. NPR.org

HHS secretary's report on: addressing surprise medical billing. ASPE. 2020

Surprise bills from outpatient providers: a national survey

Consumers' responses to surprise medical bills In elective situations

Modernizing Part D and Medicare Advantage to lower drug prices and reduce out-of-pocket expenses

Doctors slow to adopt tech tools that might save patients money on drugs. NPR.org

Cerner implements drug price transparency solution into EHR. EHRIntelligence

Epic Systems partner for prescription pricetransparency. PatientEngagementHIT

Redefining the physician's role in costconscious care: the potential role of the electronic health record

impact report: prescription price transparency

Real-time benefit tools for drug prices

Impact of displaying inpatient pharmaceutical costs at the time of order entry: lessons from a tertiary care center

The effect of medication cost transparency alerts on prescriber behavior

Medication cost information in a computer-based patient record system. Impact on prescribing in a family medicine clinical practice

Does a computerized price comparison module reduce prescribing costs in general practice?

Giving formulary and drug cost information to providers and impact on medication cost and use: a longitudinal non-randomized study

Can recommender systems reduce healthcare costs? The role of time pressure and cost transparency in prescription choice

Effect of electronic prescribing with formulary decision support on medication tier, copayments, and adherence

What is in your wallet? A cluster randomized trial of the effects of showing comparative patient out-ofpocket costs on primary care prescribing for uncomplicated hypertension

Optimizing prescribing practices of high-cost medications with computerized alerts in the inpatient setting

Clinicians' values and preferences for medication adherence and cost clinical decision support in primary care: a qualitative study

Minimizing out-of-pocket prescription drug costs for Medicare beneficiaries: not just "a drop in the bucket

Promoting access and reducing expected out-of-pocket prescription drug costs for vulnerable Medicare beneficiaries: a pharmacist-directed model

Potential impact of pharmacist interventions to reduce cost for Medicare Part D beneficiaries

The PRICE Clinic for low-income elderly: a managed care model for implementing pharmacist-directed services

Child poverty, toxic stress, and social determinants of health: screening and care coordination

Integrating the social determinants of health into nursing practice: nurses' perspectives

Roles of community helpers in using the Medicare Part D benefit

Bridging the gap between financial distress and available resources for patients with cancer: a qualitative study

Standards of Practice for Nephrology Social Work

Saturation in qualitative research: exploring its conceptualization and operationalization

The Coding Manual for Qualitative Researchers

Interrater reliability: the Kappa statistic

Establishing trustworthiness

Physician practices, e-prescribing and accessing information to improve prescribing decisions

Effects of an online personal health record on medication accuracy and safety: a cluster-randomized trial

A computer consultation program for primary care physicians: impact of decisionmaking model and explanation capability

A controlled trial of including symptom data in computer-based care suggestions for managing patients with chronic heart failure

Heart failure and shared decision making: patients open to medication-related cost discussions

Cost-related medication underuse: do patients with chronic illnesses tell their doctors?

Reducing cost-related medication nonadherence in patients with diabetes. Patient Care Online

It's a mess sometimes": Patient perspectives on provider responses to healthcare costs, and how informatics interventions can help support cost-sensitive care decisions

Communication with physicians about health care costs: survey of an insured population

Cancer cost communication: experiences and preferences of patients, caregivers, and oncologists-a nationwide triad study

Costs matter: the impact of disclosing treatment costs and provider profit on patients' decisions

Competing priorities in treatment decision-making: a US national survey of individuals with depression and clinicians who treat depression

Using shared decision-making tools and patient-clinician conversations about costs

Patient-provider communication about medication cost in rheumatoid arthritis

Show me the money: patients' perspectives on a decision aid for Sacubitril/Valsartan addressing out-of-pocket cost

The neglected topic: presentation of cost information in patient decision AIDS

Community resource referral platforms: a guide for health care organizations j SIREN

More than a database: understanding community resource referrals within a socio-technical systems framework

We thank our participants.

None declared.

The data underlying this article cannot be shared to protect the privacy of individuals that participated in the study, as they could be identifiable from the qualitative interview transcripts generated in this research.